The United States diabetes care drugs and devices market size reached USD 54.84 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 89.76 Billion by 2033, exhibiting a growth rate (CAGR) of 5.63% during 2025-2033. The market is propelled by rising prevalence of diabetes, rising healthcare spending of the population, various technological advancements, increasing awareness and education among patients, and government policies and reimbursement programs.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 54.84 Billion |
Market Forecast in 2033 | USD 89.76 Billion |
Market Growth Rate 2025-2033 | 5.63% |
Increasing Prevalence of Diabetes
The rising prevalence of diabetes in the United States is a major factor driving the market for diabetes care medications and devices. As per American Diabetes Association, in 2021, 38.4 million Americans, or 11.6% of the total population, had diabetes. 2 million Americans were with type 1 diabetes, including around 304,000 children and adolescents. Besides, 1.2 million Americans are diagnosed with diabetes every year. Obesity, bad diet, and sedentary behavior all contribute to the rising numbers. As a result, the demand for drugs like insulin, GLP-1 receptor agonists, and SGLT2 inhibitors is increasing. Furthermore, the need for monitoring equipment such as continuous glucose monitors (CGMs) and blood glucose meters is growing. This increase in demand is driving market innovation, with businesses spending in research and development activities to produce more effective and user-friendly devices that can help patients manage diabetes more effectively and enhance their quality of life.
Rising Healthcare Expenditure
The rising healthcare spending of the general population in the United States is a major driver of the diabetes care medications and devices industry. According to Centers for Medicare and Medicaid Services, the United States health care spending grew 4.1% to reach $4.5 Trillion in 2022, faster than the increase of 3.2% in 2021. Retail prescription drug spending elevated by 8.4% to $405.9 Billion in 2022, above the 6.8% increase seen in 2021. As people devote more resources to their health, there is a greater demand for complete diabetes care options. Patients with higher spending capacity have access to advanced diabetic care, including the most recent drugs and cutting-edge technologies like continuous glucose monitors (CGMs) and insulin pumps. This increased spending is also linked to a growing preference for individualized and preventive healthcare, which encourages the use of technology that improve diabetes control. With more resources available, patients are more likely to invest in high-quality, effective treatments and monitoring systems, driving the market for diabetes care medications and devices.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on offering and distribution channel.
Offering Insights:
The report has provided a detailed breakup and analysis of the market based on the offering. This includes devices [monitoring devices (self-monitoring blood glucose devices and continuous blood glucose monitoring) and management devices (insulin pump, insulin syringes, insulin cartridges, and disposable pens)] and drugs (oral anti-diabetes drugs, insulin drugs, combination drugs, and non-insulin injectable drugs).
Distribution Channel Insights:
A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes online and offline.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Northeast, Midwest, South, and West.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | USD Billion |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Offerings Covered |
|
Distribution Channels Covered | Online, Offline |
Regions Covered | Northeast, Midwest, South, West |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |